| Patent | Date |
|---|
Antimicrobial and antiviral sulfur containing glycerol monoester derivatives
Grant 11,365,176 - Reardan , et al. June 21, 2 | 2022-06-21 |
Antimicrobial And Antiviral Sulfur Containing Glycerol Monoester Derivatives
App 20220089535 - Reardan; Dayton T. ; et al. | 2022-03-24 |
Ultrapure hypoallergenic solutions of sacrosidase
Grant 10,588,947 - Reardan , et al. | 2020-03-17 |
Microbiologically Sound And Stable Solutions Of Gamma-hydroxybutyrate Salt For The Treatment Of Narcolepsy
App 20190328882 - Cook; Harry ; et al. | 2019-10-31 |
Ultrapure Hypoallergenic Solutions Of Sacrosidase
App 20180193433 - Reardan; Dayton T. ; et al. | 2018-07-12 |
Ultrapure hypoallergenic solutions of sacrosidase
Grant 9,849,161 - Reardan , et al. December 26, 2 | 2017-12-26 |
Microbiologically Sound And Stable Solutions Of Gamma-hydroxybutyrate Salt For The Treatment Of Narcolepsy
App 20170224825 - Cook; Harry ; et al. | 2017-08-10 |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Grant 9,539,330 - Cook , et al. January 10, 2 | 2017-01-10 |
Ultrapure Hypoallergenic Solutions Of Sacrosidase
App 20170000860 - Reardan; Dayton T. ; et al. | 2017-01-05 |
Ultrapure hypoallergenic solutions of sacrosidase
Grant 9,469,847 - Reardan , et al. October 18, 2 | 2016-10-18 |
Sensitive Drug Distribution System And Method
App 20160180058 - Reardan; Dayton T. ; et al. | 2016-06-23 |
Sensitive Drug Distribution System And Method
App 20160154947 - Reardan; Dayton T. ; et al. | 2016-06-02 |
Microbiologically Sound And Stable Solutions Of Gamma-hydroxybutyrate Salt For The Treatment Of Narcolepsy
App 20160058862 - Cook; Harry ; et al. | 2016-03-03 |
Ultrapure hypoallergenic solutions of sacrosidase
Grant 9,255,261 - Reardan , et al. February 9, 2 | 2016-02-09 |
Ultrapure Hypoallergenic Solutions Of Sacrosidase
App 20150343032 - Reardan; Dayton T. ; et al. | 2015-12-03 |
Ultrapure Hypoallergenic Solutions Of Sacrosidase
App 20150225707 - Reardan; Dayton T. ; et al. | 2015-08-13 |
Microbiologically Sound And Stable Solutions Of Gamma-hydroxybutyrate Salt For The Treatment Of Narcolepsy
App 20150073052 - Cook; Harry ; et al. | 2015-03-12 |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Grant 8,952,062 - Cook , et al. February 10, 2 | 2015-02-10 |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Grant 8,859,619 - Cook , et al. October 14, 2 | 2014-10-14 |
Stable Solutions Of Sacrosidase
App 20140250942 - Reardan; Dayton T. ; et al. | 2014-09-11 |
Sensitive Drug Distribution System And Method
App 20140207480 - Reardan; Dayton T. ; et al. | 2014-07-24 |
Sensitive Drug Distribution System And Method
App 20140207481 - Reardan; Dayton T. ; et al. | 2014-07-24 |
Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
Grant 8,778,301 - Mamelak , et al. July 15, 2 | 2014-07-15 |
Sensitive Drug Distribution System And Method
App 20140188504 - Reardan; Dayton T. ; et al. | 2014-07-03 |
Sensitive drug distribution system and method
Grant 8,731,963 - Reardan , et al. May 20, 2 | 2014-05-20 |
Method Of Administering Ethanolamine 9-octadecanoic Acid Via Injection To The Stomach Of A Human
App 20140107204 - Reardan; Dayton T. ; et al. | 2014-04-17 |
Gamma-hydroxybutyrate Compositions Containing Carbohydrate, Lipid Or Amino Acid Carriers
App 20130324759 - Mamelak; Mortimer ; et al. | 2013-12-05 |
Sensitive drug distribution system and method
Grant 8,589,182 - Reardan , et al. November 19, 2 | 2013-11-19 |
Microbiologically Sound And Stable Solutions Of Gamma-hydroxybutyrate Salt For The Treatment Of Narcolepsy
App 20130267595 - Cook; Harry ; et al. | 2013-10-10 |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Grant 8,461,203 - Cook , et al. June 11, 2 | 2013-06-11 |
Microbiologically Sound And Stable Solutions Of Gamma-hydroxybutyrate Salt For The Treatment Of Narcolepsy
App 20130143965 - Cook; Harry ; et al. | 2013-06-06 |
Sensitive drug distribution system and method
Grant 8,457,988 - Reardan , et al. June 4, 2 | 2013-06-04 |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Grant 8,324,275 - Cook , et al. December 4, 2 | 2012-12-04 |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Grant 8,263,650 - Cook , et al. September 11, 2 | 2012-09-11 |
Sensitive Drug Distribution System And Method
App 20120209623 - Reardan; Dayton T. ; et al. | 2012-08-16 |
Methods for modulating the efficacy of nucleic acid based therapies
Grant 7,960,364 - Reardan , et al. June 14, 2 | 2011-06-14 |
Sensitive Drug Distribution System And Method
App 20110119085 - Reardan; Dayton T. ; et al. | 2011-05-19 |
Sensitive drug distribution system and method
Grant 7,895,059 - Reardan , et al. February 22, 2 | 2011-02-22 |
Microbiologically Sound And Stable Solutions Of Gamma-hydroxybutyrate Salt For The Treatment Of Narcolepsy
App 20110039929 - Cook; Harry ; et al. | 2011-02-17 |
Sensitive drug distribution system and method
Grant 7,797,171 - Reardan , et al. September 14, 2 | 2010-09-14 |
Sensitive drug distribution system and method
Grant 7,765,106 - Reardan , et al. July 27, 2 | 2010-07-27 |
Sensitive drug distribution system and method
Grant 7,765,107 - Reardan , et al. July 27, 2 | 2010-07-27 |
Methods for Modulating the Efficacy of Nucleic Acid Based Therapies
App 20100144840 - Reardan; Dayton T. ; et al. | 2010-06-10 |
Sensitive Drug Distribution System And Method
App 20100138237 - Reardan; Dayton T. ; et al. | 2010-06-03 |
Sensitive drug distribution system and method
Grant 7,668,730 - Reardan , et al. February 23, 2 | 2010-02-23 |
Gamma-hydroxybutyrate Compositions Containing Carbohydrate, Lipid Or Amino Acid Carriers
App 20090215890 - Mamelak; Mortimer ; et al. | 2009-08-27 |
Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
Grant 7,572,605 - Mamelak , et al. August 11, 2 | 2009-08-11 |
Ultrapure 4-methylpyrazole
Grant 7,553,863 - Reardan , et al. June 30, 2 | 2009-06-30 |
Methods for Modulating the Efficacy of Nucleic Acid Based Therapies
App 20080167263 - Reardan; Dayton T. ; et al. | 2008-07-10 |
Ultrapure 4-methylpyrazole
App 20070244330 - Reardan; Dayton T. ; et al. | 2007-10-18 |
Method and composition for inhibiting cholesterol esterase
Grant 7,071,174 - Lange, III , et al. July 4, 2 | 2006-07-04 |
Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
Grant 7,015,200 - Mamelak , et al. March 21, 2 | 2006-03-21 |
Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
App 20050250848 - Mamelak, Mortimer ; et al. | 2005-11-10 |
Sensitive drug distribution system and method
App 20050222874 - Reardan, Dayton T. ; et al. | 2005-10-06 |
Sensitive drug distribution system and method
App 20050216309 - Reardan, Dayton T. ; et al. | 2005-09-29 |
Sensitive drug distribution system and method
App 20050090425 - Reardan, Dayton T. ; et al. | 2005-04-28 |
Sensitive drug distribution system and method
App 20040117205 - Reardan, Dayton T. ; et al. | 2004-06-17 |
Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
App 20040092455 - Mamelak, Mortimer ; et al. | 2004-05-13 |
Method and composition for inhibiting human cholesterol esterase
Grant 6,632,801 - Lange, III , et al. October 14, 2 | 2003-10-14 |
Activated polymers and conjugates thereof
Grant 5,090,914 - Reardan , et al. February 25, 1 | 1992-02-25 |
Activated polyers and conjugates thereof
Grant 5,081,295 - Reardan , et al. January 14, 1 | 1992-01-14 |
Linking agents and methods
Grant 4,970,303 - Reardan , et al. November 13, 1 | 1990-11-13 |
| 